Softbank Group Corp Pacific Biosciences Of California, Inc. Transaction History
Softbank Group Corp
- $23.8 Billion
- Q2 2025
A detailed history of Softbank Group Corp transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Softbank Group Corp holds 20,451,570 shares of PACB stock, worth $24.7 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
20,451,570
Previous 20,451,570
-0.0%
Holding current value
$24.7 Million
Previous $24.1 Million
5.08%
% of portfolio
0.11%
Previous 0.08%
Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
243Shares Held
199MCall Options Held
879KPut Options Held
847K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$43.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$28.6 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$20.3 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$19.4 Million0.0% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V813.4MShares$16.2 Million0.27% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $272M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...